Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (No. 82270178, 82070133)
  • Natural Science Foundation of Guangdong Province (No. 2023A1515010111, 2021A1515012103)

This publication has 21 references indexed in Scilit: